By the end of September, U.S. households can again get four of the tests for free from the government
Stroke Was Third Most Common GBD Level 3 Cause of Death in 2021
93.8 million prevalent strokes, 11.9 million incident strokes recorded in 2021; disparities seen in burden by GBD region, country or territory, SDI
Vaccinated Children Can Die From Influenza
The U.S. Centers for Disease Control and Prevention (CDC) and the National Center for Immunization and Respiratory Diseases recently reported two additional flu-related deaths, bringing the total number of pediatric deaths for the 2023-2024 season to 199.
As of September 18, 2024, this number equals the previous high reported during the 2019-2020 flu season. It's a profoundly tragic reminder that influenza can cause severe illness, even after a child has been vaccinated.
Metformin Use Tied to Lower Incidence of Death, Long COVID After COVID-19
Incidence of death or postacute sequelae of SARS-CoV-2 slightly lower with prevalent metformin use
Mild Initial Clinical Course Seen for COVID-19 Vaccine-Linked Myocarditis
Late gadolinium enhancement on cardiac magnetic resonance imaging more prevalent in C-VAM than MIS-C
Cases of COVID-19 in Those With Epilepsy Low Early in the Pandemic
People with epilepsy did not report difficulty in accessing epilepsy care
Trends in Prehospital Encounters for Youth Opioid Overdose Identified
Significant increase seen in prepandemic EMS encounters, followed by immediate, significant increase with pandemic interruption
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine
Safety profile similar to other trials, with six in 10 sustaining medication overuse headache remission over six months
Postpartum Anxiety, Depression Not Up After Pandemic Onset, but Benzodiazepine Rx Increased
No increase observed in diagnoses following onset of COVID-19, but increase seen in proportion of women filling benzodiazepine prescription
Another Herpes Vaccine Candidate Flops
Given the unmet medical need and burden associated with genital herpes, the approval of an innovative vaccine is much anticipated. Unfortunately, developing protective herpes simplex virus (HSV) vaccines has been challenging for decades.
However, the wait will continue according to GSK plc's recent announcement.